FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Invent Medic Sweden AB's FCF Yield % or its related term are showing as below:
XSAT:IMS'
s FCF Yield % Range Over the Past 10 Years
Min: -216.51 Med: -28.54 Max: -5.28
Current: -31.95
During the past 10 years, the highest FCF Yield % of Invent Medic Sweden AB was -5.28%. The lowest was -216.51%. And the median was -28.54%.
XSAT:IMS's FCF Yield % is ranked worse than 87.35% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: -0.385
vs XSAT:IMS: -31.95
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Invent Medic Sweden AB FCF Yield % Related Terms
Invent Medic Sweden AB FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Invent Medic Sweden AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Invent Medic Sweden AB FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Invent Medic Sweden AB's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Invent Medic Sweden AB's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invent Medic Sweden AB (XSAT:IMS) has a FCF Yield % of -31.95 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Invent Medic Sweden AB and its competitors. According to the industry distribution chart, Invent Medic Sweden AB ranks #746 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 87.4%.
Is Invent Medic Sweden AB's FCF Yield % too high?
Invent Medic Sweden AB's current FCF Yield % is -31.95. Based on the distribution chart, Invent Medic Sweden AB ranks #746 out of 854 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Invent Medic Sweden AB has a GF Score™ of 38/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Invent Medic Sweden AB's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Invent Medic Sweden AB ranks #746 out of 854 companies for FCF Yield %. This places Invent Medic Sweden AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Invent Medic Sweden AB and its competitors. Invent Medic Sweden AB's current FCF Yield % is -31.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invent Medic Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Invent Medic Sweden AB (XSAT:IMS) is currently considered Significantly Undervalued. The stock's GF Value™ is kr0.18, compared to a current price of kr0.12 — trading 32.8% below its estimated fair value. The current FCF Yield % is -31.95. Invent Medic Sweden AB's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Invent Medic Sweden AB (XSAT:IMS), the current FCF Yield % is -31.95 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Invent Medic Sweden AB (XSAT:IMS) Overvalued in 2026?
Based on GuruFocus' analysis, Invent Medic Sweden AB stock appears to be undervalued.
The current stock price of kr0.12 is trading 32.8% below its estimated GF Value™ of kr0.18.
GuruFocus considers Invent Medic Sweden AB to be Significantly Undervalued.
Key valuation signals for XSAT:IMS:
FCF Yield %: -31.95
GF Value™: kr0.18 vs. price of kr0.12 (32.8% below fair value)
No single metric tells the full story. See the XSAT:IMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Invent Medic Sweden AB develops and markets its product - Efemia bladder support, a vaginal medical device for the treatment of female urinary incontinence.
38GF Score
Get the complete analysis for XSAT:IMS
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:IMS has been successfully added to your 
